Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Pharmaceutical Research|October 15, 2015
Preclinical Pharmacokinetics Evaluation of Anti-heparin-binding EGF-like Growth Factor (HB-EGF) Monoclonal Antibody Using Cynomolgus Monkeys via (89)Zr-immuno-PET Study and the Determination of Drug Concentrations in Serum and Cerebrospinal FluidNoriyuki Kasai, Maiko Adachi, Kazuya YamanoJournal of Cutaneous Pathology|August 22, 2006
Onycholemmal carcinomaMakoto Inaoki, Eiichi Makino, Maiko Adachi, et al.Kekkaku : [Tuberculosis]|January 16, 2019
[DOTS AND TREATMENT RESULTS IN PATIENTS WITH EXTRA-PULMONARY TUBERCULOSIS IN OSAKA CITY]Kenji Matsumoto, Jun Komukai, Yuko Tsuda, et al.Kekkaku : [Tuberculosis]|January 16, 2019
[TREATMENT SUPPORT AND TREATMENT QUTCOMES OF PULMONARY TUBERCULOSIS IN PATIENTS WITH HIV INFECTION IN OSAKA CITY]Kenji Matsumoto, Jun Komukai, Yuko Tsuda, et al.Cancer Science|October 9, 2024
The novel and potent CD40 agonist KHK2840 augments the antitumor efficacy of anti-PD-1 antibody and paclitaxelChiaki Kobayashi, Minami Suzuki-Imaizumi, Yasuko Sakaguchi, et al.Leukemia|May 22, 2025
KK2845, a PBD dimer-containing antibody-drug conjugate targeting TIM-3-expressing AMLJian Zou, Haruka Kinosada, Shin-Ichiro Takayanagi, et al.Translational Oncology|July 16, 2017
Potent Therapeutic Activity Against Peritoneal Dissemination and Malignant Ascites by the Novel Anti-Folate Receptor Alpha Antibody KHK2805Munetoshi Ando, Keiko Nagata, Kaito Nihira, et al.Internal Medicine (Tokyo, Japan)|February 23, 2026
An Effective Case of Radiofrequency Ablation with the Combination of Durvalumab and Tremelimumab Treatment for Hepatocellular Carcinoma: A Case ReportKoji Rinka, Kiyohide Kioka, Rika Shioji, et al.Drug Metabolism and Pharmacokinetics|April 4, 2018
Collaborative study using common samples to evaluate the performance of anti-drug antibody assays constructed by different companiesShingo Niimi, Kazuhiro Nishimiya, Masanobu Nishidate, et al.Pageof 1